← Alle mensen

TP

Tomás Pascual

9 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Gevorderd Breast Cancer...
Clinical cancer research : an official journal of the American Association for Cancer Research · 17 februari 2026
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analyse.
The Lancet. Oncology · 2025-08
Neoadjuvante therapie bij HER2-positief mammacarcinoom: NMA van schema's
European journal of cancer (Oxford, England : 1990) · 2023-09
Immuun-gensignaturen versus TILs bij mammacarcinoom: prognostische en predictieve waarde
JAMA oncology · 1 april 2023
Preoperatieve ribociclib-letrozol versus chemotherapie: QoL FELINE analyse
European journal of cancer (Oxford, England : 1990) · 2022-10
PAM50MET prognostisch model bij gemetastaseerd HR-positief mammacarcinoom
Clinical cancer research : an official journal of the American Association for Cancer Research · 1 december 2020
Palbociclib plus trastuzumab bij HER2-positief gevorderd mammacarcinoom: SOLTI-1303 PATRICIA fase II
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 november 2020
Multivariabele prognostische score bij HER2-positief vroeg mammacarcinoom
The Lancet. Oncology · 2020-11
Ribociclib plus letrozol versus chemotherapie bij postmenopauzaal HR-positief mammacarcinoom: RIGHT Choice
The Lancet. Oncology · 2020-01